Thomas Nee is a commercial valuation and strategic marketing executive, recognized for his extensive experience evaluating deals and driving acquisition strategy in fast-moving, high-growth businesses. He has a broad and deep financial expertise, with a global perspective that spans commercial valuations, product management, analytics, and brand and product marketing in the pharmaceutical industry. As a skilled Leader Thomas provided strategic leadership and direction for dozens of successful pharmaceutical products that contributed more than $1.5 billion in annual revenue. Adept at leading all parts of the product lifecycle. Managed flagship brands, new products and generics through launches, relaunches and turnarounds. Thomas is seen as a strategic dealmaker known for quickly identifying opportunities, mitigating risk, and creating the framework for growth. Assessed, or led teams that assessed, the commercial viability of more than 150 internal and external assets a year. Driven by predictive insights validated through analytics, Thomas is skilled in determining unique strengths, opportunities and differentiators. Skilled at developing best- and alternate-case scenarios, and driving robust launch and growth plans to extend market share and revenue goals. He is seen by his team as an experienced leader and a trusted partner to ensure productivity and operational success through extended periods of business acquisitions, reorganizations and change.
Listed skills include Pharmaceutical Industry, Oncology, Cross Functional Team Leadership, Mergers And Acquisitions, and 17 others.
